Company Number: 12774304

Analysis Date: 2025-07-20 18:36 UTC

Financial Health Assessment – FARWAY247 LIMITED (Year ended 31 July 2024)

---

1. Financial Health Score: C

Explanation:
This score reflects a company showing signs of financial stress with a marked decline in net assets and working capital over the last year. While still solvent with positive net assets, the sharp reduction from previous years indicates weakened "financial vitality". The company is not in immediate distress but requires close attention to avoid deterioration.

---

2. Key Vital Signs

Metric	2024 (£)	2023 (£)	Interpretation
Current Assets	71,573	160,329	Sharp decrease in liquid resources – potential cash flow concerns.
Current Liabilities	64,736	103,770	Decrease in short-term debts, but still close to current assets.
Net Current Assets (Working Capital)	6,837	56,559	Working capital shrank drastically, indicating reduced buffer for day-to-day operations.
Net Assets / Shareholders' Funds	5,709	55,547	Net worth shrank by ~90%, signaling erosion of company value.
Share Capital	400	400	Stable but minimal capital base.
Staff Numbers	4	4	Stable workforce size.

• Liquidity: The sharp drop in current assets compared to liabilities has reduced the working capital to a thin margin (£6.8k), indicating a fragile liquidity position — akin to a patient with weakened pulse.
• Solvency: Positive net assets mean the company remains solvent, but the steep decline resembles symptoms of underlying financial strain.
• Capital Structure: The very low share capital and erosion of reserves mean the company has limited equity cushion against operational shocks.
• Related Party Transactions: Interest-free loans to directors, repaid post year-end, suggest reliance on internal funding support during the year.

---

3. Diagnosis

The financial "symptoms" in FARWAY247 LIMITED's latest accounts indicate a company under strain. The drastic reduction in net assets and working capital signals deteriorating financial health — potentially due to operational challenges or reduced cash inflows. The company still "breathes" with positive net assets, but the sharp contraction from around £55,500 to just £5,700 is worrying.

The liquidity position is thin, leaving little room for unexpected expenses or delays in payments. This is comparable to a patient with low stamina and diminished reserves, requiring careful monitoring. The stable staffing level suggests the company has not yet resorted to downsizing, but the cash position may limit flexibility.

The use of director loans, though repaid, highlights reliance on internal support, sometimes a sign of cash flow tightness.

---

4. Recommendations

To improve financial wellness and strengthen resilience, the company should consider the following "treatment plan":

• Improve Cash Flow Management:
  Tighten controls on receivables and payables to ensure healthy liquidity. Explore strategies to accelerate cash inflows and defer non-essential outflows.

• Increase Working Capital:
  Seek additional equity investment or external financing to boost net current assets, providing a more robust buffer against operational risks.

• Cost Control & Efficiency:
  Review operational costs and identify areas for efficiency gains to improve margins and preserve cash.

• Financial Monitoring:
  Establish regular financial health checks focusing on liquidity ratios and net asset trends to detect early warning signs.

• Strategic Review:
  Evaluate business model and revenue streams to understand causes of financial contraction and take corrective action.

• Transparent Reporting:
  Continue timely and accurate filings to maintain stakeholder confidence and comply with regulatory requirements.

---

Executive Summary